CA Patent

CA3175830A1 — Prodrugs of monomethyl fumarate

Assigned to Myto Therapeutics Inc · Expires 2020-10-22 · 6y expired

What this patent protects

Provided herein are novel monomethyl fumarate prodrugs.

USPTO Abstract

Provided herein are novel monomethyl fumarate prodrugs.

Drugs covered by this patent

Vumerity (DIROXIMEL FUMARATE) · Biogen

Patent Metadata

Patent number: CA3175830A1
Jurisdiction: CA
Classification: —
Expires: 2020-10-22
Drug substance claim: No
Drug product claim: No
Assignee: Myto Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.